Num
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
A icle
De San is O, Aud an R, Po hin E, e al. Sa e y and immunogenici y o a chimpanzee adeno i us- ec o ed Ebola accine in heal hy adul s: a andomised, double-blind, placebo-con olled, dose- inding, phase 1/2a s udy. Lance In ec Dis. 2016;16(3):311-320. doi:10.1016/S1473-3099(15)00486-7
Halle MJ, A kinson MA, Wasse all CH, e al. Mobiliza ion wi hou immune deple ion ails o es o e immunological ole ance o p ese e be a cell unc ion in ecen onse ype 1 diabe es. Clin Exp Immunol. 2016;183(3):350-357. doi:10.1111/cei.12731
Fische K, Bahlo J, Fink AM, e al. Long- e m emissions a e FCR chemoimmuno he apy in p e iously un ea ed pa ien s wi h CLL: upda ed esul s o he CLL8 ial. Blood. 2016;127(2):208-215. doi:10.1182/blood-2015-06-651125
Beachle DC, K eime AR, Schi man M, e al. Mul isi e HPV16/18 Vaccine E icacy Agains Ce ical, Anal, and O al HPV In ec ion. J Na l Cance Ins . 2015;108(1):dj 302. Published 2015 Oc 14. doi:10.1093/jnci/dj 302
Rapapo MH, Nie enbe g AA, Sche le PJ, e al. In lamma ion as a p edic i e bioma ke o esponse o omega-3 a y acids in majo dep essi e diso de : a p oo -o -concep s udy. Mol Psychia y. 2016;21(1):71-79. doi:10.1038/mp.2015.22
Landin H, Mö k MJ, La sson M, Walle KP. Vaccina ion agains S aphylococcus au eus mas i is in wo Swedish dai y he ds. Ac a Ve Scand. 2015;57:81. Published 2015 No 25. doi:10.1186/s13028-015-0171-6
Raa z SK, Johnson LK, Picklo MJ. Consump ion o Honey, Suc ose, and High-F uc ose Co n Sy up P oduces Simila Me abolic E ec s in Glucose-Tole an and -In ole an Indi iduals. J Nu . 2015;145(10):2265-2272. doi:10.3945/jn.115.218016
Geno ese MC, Hsia E, Belkowski SM, e al. Resul s om a Phase IIA Pa allel G oup S udy o JNJ-40346527, an O al CSF-1R Inhibi o , in Pa ien s wi h Ac i e Rheuma oid A h i is despi e Disease-modi ying An i heuma ic D ug The apy. J Rheuma ol. 2015;42(10):1752-1760. doi:10.3899/j heum.141580
Ma JK, D ossa d J, Lewis D, e al. Regula o y app o al and a i s -in-human phase I clinical ial o a monoclonal an ibody p oduced in ansgenic obacco plan s. Plan Bio echnol J. 2015;13(8):1106-1120. doi:10.1111/pbi.12416
Mily A, Rekha RS, Kamal SM, e al. Signi ican E ec s o O al Phenylbu y a e and Vi amin D3 Adjunc i e The apy in Pulmona y Tube culosis: A Randomized Con olled T ial. PLoS One. 2015;10(9):e0138340. Published 2015 Sep 22. doi:10.1371/jou nal.pone.0138340
Bha ia A, Sha ma RK, Tewa i S, Na ula SC. A andomized clinical ial o sali a y subs i u e as an adjunc o scaling and oo planing o managemen o pe iodon al in lamma ion in mou h b ea hing pa ien s. J O al Sci. 2015;57(3):241-247. doi:10.2334/josnusd.57.241
And es C, Plana M, Gua do AC, e al. HIV-1 Rese oi Dynamics a e Vaccina ion and An i e o i al The apy In e up ion A e Associa ed wi h Dend i ic Cell Vaccine-Induced T Cell Responses. J Vi ol. 2015;89(18):9189-9199. doi:10.1128/JVI.01062-15
Deb ah AY, Spech S, Kla mann-Schulz U, e al. Doxycycline Leads o S e ili y and Enhanced Killing o Female Onchoce ca ol ulus Wo ms in an A ea Wi h Pe sis en Mic o ila ide mia A e Repea ed I e mec in T ea men : A Randomized, Placebo-Con olled, Double-Blind T ial. Clin In ec Dis. 2015;61(4):517-526. doi:10.1093/cid/ci 363
Hun e DJ, Bea e s DP, Ecks ein F, e al. The In ensi e Die and Exe cise o A h i is (IDEA) ial: 18-mon h adiog aphic and MRI ou comes. Os eoa h i is Ca ilage. 2015;23(7):1090-1098. doi:10.1016/j.joca.2015.03.034
Nilsson C, Hejdeman B, Godoy-Rami ez K, e al. HIV-DNA Gi en wi h o wi hou In ade mal Elec opo a ion Is Sa e and Highly Immunogenic in Heal hy Swedish HIV-1 DNA/MVA Vaccinees: A Phase I Randomized T ial. PLoS One. 2015;10(6):e0131748. Published 2015 Jun 29. doi:10.1371/jou nal.pone.0131748
Lo MM, Mbao V, Sie a P, e al. Sa e y and immunogenici y o Onde s epoo Biological P oduc s' Ri Valley e e Clone 13 accine in sheep and goa s unde ield condi ions in Senegal. Onde s epoo J Ve Res. 2015;82(1):857. Published 2015 May 29. doi:10.4102/oj . 82i1.857
Fuchs CS, Aze edo S, Okusaka T, e al. A phase 3 andomized, double-blind, placebo-con olled ial o gani umab o placebo in combina ion wi h gemci abine as i s -line he apy o me as a ic adenoca cinoma o he panc eas: he GAMMA ial. Ann Oncol. 2015;26(5):921-927. doi:10.1093/annonc/md 027
Joachim A, Nilsson C, Aboud S, e al. Po en unc ional an ibody esponses elici ed by HIV-I DNA p iming and boos ing wi h he e ologous HIV-1 ecombinan MVA in heal hy Tanzanian adul s. PLoS One. 2015;10(4):e0118486. Published 2015 Ap 14. doi:10.1371/jou nal.pone.0118486
Whea ley CM, Bake SE, Mo gan MA, e al. E ec s o exe cise in ensi y compa ed o albu e ol in indi iduals wi h cys ic ib osis. Respi Med. 2015;109(4):463-474. doi:10.1016/j. med.2014.12.002
T e en P, M ak V, Bogo ič Ma ijašić B, Ho a S, Rogelj I. Adminis a ion o p obio ics Lac obacillus hamnosus GG and Lac obacillus gasse i K7 du ing p egnancy and lac a ion changes mouse mesen e ic lymph nodes and mamma y gland mic obio a. J Dai y Sci. 2015;98(4):2114-2128. doi:10.3168/jds.2014-8519
LLM: Claude Sonne 4
DOI 1a 1b 2a 2b 3a
h ps://doi.o g/10.1016/S1473-3099(15)00486-7 Yes Yes Yes Yes Yes
h ps://doi.o g/10.1111/cei.12731 No Yes Yes Yes Pa ially
h ps://doi.o g/10.1182/blood-2015-06-651125 Pa ially Yes Yes Yes Yes
h ps://doi.o g/10.1093/jnci/dj 302 Yes Yes Yes Yes Yes
h ps://doi.o g/10.1038/mp.2015.22 Yes Yes Yes Yes Yes
h ps://doi.o g/10.1186/s13028-015-0171-6 No No Yes Yes Yes
h ps://doi.o g/10.3945/jn.115.218016 No Pa ially Yes Yes Pa ially
h ps://doi.o g/10.3899/j heum.141580 Yes Yes Yes Yes Yes
h ps://doi.o g/10.1111/pbi.12416 Yes Yes Yes Yes Pa ially
h ps://doi.o g/10.1371/jou nal.pone.0138340 Yes Yes Yes Yes Yes
h ps://doi.o g/10.2334/josnusd.57.241 Yes Yes Yes Yes Yes
h ps://doi.o g/10.1128/JVI.01062-15 No Pa ially Yes Yes Yes
h ps://doi.o g/10.1093/cid/ci 363 Yes Yes Yes Yes Yes
h ps://doi.o g/10.1016/j.joca.2015.03.034 Yes Yes Yes Yes Yes
h ps://doi.o g/10.1371/jou nal.pone.0131748 Yes Yes Yes Yes Yes
h ps://doi.o g/10.4102/oj . 82i1.857 No Pa ially Yes Yes Yes
h ps://doi.o g/10.1093/annonc/md 027 Yes Yes Yes Yes Yes
h ps://doi.o g/10.1371/jou nal.pone.0118486 Yes Yes Yes Yes Yes
h ps://doi.o g/10.1016/j. med.2014.12.002 No Yes Yes Yes Yes
h ps://doi.o g/10.3168/jds.2014-8519 No Yes Yes Yes Yes
3b 4a 4b 56a 6b 7a 7b 8a
No Yes Yes Yes Yes No Yes Pa ially Yes
No Yes Yes Yes Yes No No No No
No Yes Yes Yes Yes No Yes No No
No Yes Yes Yes Yes No No No No
No Yes Yes Yes Yes No Yes No Pa ially
No Yes Yes Yes Yes No No No No
No Yes Yes Yes Yes No Pa ially No Pa ially
No Yes Yes Yes Yes No Yes No Yes
No Yes Yes Yes Yes No No No Pa ially
Pa ially Yes Yes Yes Yes No Yes No Yes
No Yes Yes Yes Yes No Yes No Yes
No Yes Pa ially Yes Yes No No No No
No Yes Yes Yes Yes No Yes No Yes
No Yes Yes Yes Yes No No No No
No Yes Yes Yes Yes No Yes Pa ially No
No Yes Yes Yes Yes No No No No
No Yes Yes Yes Yes Yes Yes Yes Yes
No Yes Yes Yes Yes No Yes No No
No Yes Yes Yes Yes No No No No
No Yes Yes Yes Yes No No No No
8b 910 11a 11b 12a 12b 13a 13b
Yes Yes Yes Yes Yes Yes Yes Yes Yes
Pa ially No No Pa ially Yes Yes Yes Pa ially Pa ially
No No No Yes No Yes Yes Yes Yes
No No No Yes No Yes Yes Yes Yes
No Pa ially Pa ially Pa ially No Yes Yes Yes Yes
No No No No No Yes Yes Pa ially Yes
No Pa ially No Pa ially Pa ially Yes Yes Yes Yes
Yes Yes Yes Yes Yes Yes Yes Yes Yes
No Pa ially Pa ially Yes Yes No No Yes Yes
Yes Yes Pa ially Yes Yes Yes Yes Yes Yes
Yes Pa ially Pa ially Yes No Yes Pa ially Yes Yes
Yes No No Yes No Yes Yes Yes No
Yes Yes Yes Yes Yes Yes Yes Yes Yes
No No No No No Yes Yes Yes Yes
Pa ially Yes Yes Yes Yes Yes Yes Yes Yes
No No No Yes Pa ially Yes No Yes Yes
Yes Yes Yes Yes Yes Yes Yes Yes Yes
No No No Pa ially Yes Yes Yes Pa ially No
No No No No No Yes No Yes Yes
No No No No No Yes No Yes Yes
14a 14b 15 16 17a 17b 18 19 20
Yes No Yes Yes Yes Pa ially Yes Yes Yes
No No Yes Pa ially Pa ially No Pa ially Yes Yes
Yes No Yes Yes Yes No No Yes Yes
Yes No Yes Yes Yes Pa ially Yes No Yes
Yes No Yes Yes Yes No Pa ially No Yes
Yes No Yes Yes Yes Yes Yes No Yes
Yes No Yes Yes Yes No Pa ially Yes Yes
Yes Yes Yes Yes Yes Pa ially Yes Yes Yes
Yes No No No No No No Yes Pa ially
Yes No Yes Yes Yes Pa ially Yes Yes Yes
Pa ially Yes Yes Yes Yes No No No Yes
No No Yes Yes Yes No Yes No Yes
No No Yes Yes Yes No Yes Yes Yes
Yes No Yes Yes Yes No No No Yes
Yes Yes Yes Yes Yes Yes Yes Yes Yes
Yes No Yes Yes Yes No No No Pa ially
Yes Yes Yes Yes Yes Pa ially Yes Yes Yes
No No No Pa ially Pa ially No Yes No Pa ially
Yes No Yes Yes Yes Yes No Yes Yes
Yes No Yes Yes Yes No No No Yes
sem 1.28 1.22 0.55 -3%
s d 5.72 5.44 2.45 -15%
a g 23.65 10.60 2.70 -68%
21 22 23 24 25 YES NO PARTIALLY Coun CLAUDE
Yes Yes Yes No Yes 31 4 2 37 86.50%
Yes Yes No No Yes 16 13 837 54.10%
Yes Yes No Yes Yes 24 12 137 66.20%
Yes Yes Yes No Yes 24 12 137 66.20%
Yes Yes No No Yes 22 10 537 66.20%
Yes Yes No No Yes 20 16 137 55.40%
Yes Yes Yes Yes Yes 21 8 8 37 67.60%
Yes Yes Yes Pa ially Yes 32 3 2 37 89.20%
Yes Yes Yes No Yes 18 14 537 55.40%
Yes Yes Yes No Yes 30 4 3 37 85.10%
Yes Yes No No Yes 24 9 4 37 70.30%
Yes Yes Yes No Yes 20 15 237 56.80%
Yes Yes Yes No Yes 30 7 0 37 81.10%
Yes Yes No No Yes 21 16 037 56.80%
Yes Yes Yes Yes Yes 32 3 2 37 89.20%
Yes Yes No No Yes 18 16 337 52.70%
Yes Yes Yes Pa ially Yes 34 1 2 37 94.60%
Yes Yes Yes Yes Yes 19 13 537 58.10%
Yes No No No 19 17 036 51.40%
Yes Yes No No No 18 19 037 48.60%
2% 3% 2% 5% 10% 0% 4%
9% 15% 17% 22% 44% 0% 30%
81% 55% 68% 5% 25% 0% 10%
CHATGPT GEMINI COMBINED >90% >90% >90% COMBINED
94.60% 75.70% - 0 1 0 -
75.70% 44.40% - 0 0 0 -
78.40% 58.30% - 0 0 0 -
75.70% 54.10% - 0 0 0 -
75.70% 51.40% - 0 0 0 -
59.50% 35.10% - 0 0 0 -
83.80% 35.10% - 0 0 0 -
81.10% 51.40% - 0 0 0 -
77.00% 51.40% - 0 0 0 -
75.70% 51.40% - 0 0 0 -
78.40% 40.50% - 0 0 0 -
81.10% 39.20% - 0 0 0 -
83.80% 83.80% - 0 0 0 -
86.50% 54.10% - 0 0 0 -
90.50% 78.40% - 0 1 0 -
73.00% 64.90% - 0 0 0 -
94.60% 78.40% - 1 1 0 -
93.20% 58.10% - 0 1 0 -
90.50% 56.80% - 0 1 0 -
70.30% 39.20% - 0 0 0 -
